Italian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
diabetes mellitus type 2/carbohydrate
Il collegamento viene salvato negli appunti
Pagina 1 a partire dal 18 risultati
Phenyl-1,2,4-oxadiazolone derivatives, processes for their preparation and methods for their use as pharmaceuticals
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
The present invention relates generally to pharmaceutical compositions for the treatment of metabolic disorders and the diseases and the physiological manifestations resulting therefrom. More specifically, the present invention relates to phenyl- and
Heterocyclic amide derivatives for the treatment of diabetes and other diseases
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
Type 2 diabetes, also referred to as non-insulin dependent diabetes mellitus (NIDDM), afflicts between 80 and 90% of all diabetic patients in developed countries. In the United States alone, approximately 15 million people, and more than 100 million worldwide, are
Method and apparatus for computer modeling diabetes
Solo gli utenti registrati possono tradurre articoli
Entra registrati
COPYRIGHT NOTICE
A portion of the disclosure of the patent document contains material that is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document of the patent disclosure, as it appears in the Patent and Trademark
7-azaindoles, pharmaceutical compositions and their therapeutic applications
Solo gli utenti registrati possono tradurre articoli
Entra registrati
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a continuation of International Patent Application No. PCT/EP2005/009269 filed on Aug. 27, 2005 which is incorporated herein by reference in its' entirety which also claims the benefit of priority of European Patent Application No.
Method for treatment of diabetes by a small molecule inhibitor for GRK5
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is related to compound capable of modulating the activity and/or expression of certain protein kinases thereby enhancing the expression and/or release of insulin. The invention is further related to methods of identifying
Compositions and methods to lower glycohemoglobin levels
Solo gli utenti registrati possono tradurre articoli
Entra registrati
TECHNICAL FIELD
This invention relates to glycohemoglobin levels, and more particularly to a compositions and methods to lower glycohemoglobin levels.
BACKGROUND
The glucose absorbed following the ingestion of glucose-containing foods is largely responsible for a rise in the circulating glucose
Bicyclic heterocycles for the treatment of diabetes and other diseases
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
Type 2 diabetes, also referred to as non-insulin dependent diabetes mellitus (NIDDM), afflicts between 80 and 90% of all diabetic patients in developed countries. In the United States alone, approximately 15 million people, and more than 100 million worldwide, are
Heterocyclic derivatives for the treatment of diabetes and other diseases
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
Type 2 diabetes, also referred to as non-insulin dependent diabetes mellitus (NIDDM), afflicts between 80 and 90% of all diabetic patients in developed countries. In the United States alone, approximately 15 million people, and more than 100 million worldwide, are
Substituted heterocycles for the treatment of diabetes and other diseases
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
Type 2 diabetes, also referred to as non-insulin dependent diabetes mellitus (NIDDM), afflicts between 80 and 90% of all diabetic patients in developed countries. In the United States alone, approximately 15 million people, and more than 100 million worldwide, are
Imidazolidinedione derivatives for the treatment of diabetes and other diseases
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
Type 2 diabetes, also referred to as non-insulin dependent diabetes mellitus (NIDDM), afflicts between 80 and 90% of all diabetic patients in developed countries. In the United States alone, approximately 15 million people, and more than 100 million worldwide, are
Thiazolidinedione derivatives for the treatment of diabetes and other diseases
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
Type 2 diabetes, also referred to as non-insulin dependent diabetes mellitus (NIDDM), afflicts between 80 and 90% of all diabetic patients in developed countries. In the United States alone, approximately 15 million people, and more than 100 million worldwide, are
Peptides, derivatives and analogs thereof, and methods of using same
Solo gli utenti registrati possono tradurre articoli
Entra registrati
REFERENCE TO GOVERNMENT GRANT
Not Applicable.
JOINT RESEARCH AGREEMENT
Not Applicable.
FIELD OF THE INVENTION
The present invention provides peptides and analogs thereof and methods of using them for treating type 1 diabetes mellitus, type 2 diabetes mellitus and other conditions. The invention
Peptides, derivatives and analogs thereof, and methods of using same
Solo gli utenti registrati possono tradurre articoli
Entra registrati
REFERENCE TO GOVERNMENT GRANT
Not Applicable.
JOINT RESEARCH AGREEMENT
Not Applicable.
FIELD OF THE INVENTION
The present invention provides peptides and analogs thereof and methods of using them for treating type 1 diabetes mellitus, type 2 diabetes mellitus and other conditions. The invention
Peptides, derivatives and analogs thereof, and methods of using same
Solo gli utenti registrati possono tradurre articoli
Entra registrati
REFERENCE TO GOVERNMENT GRANT
NOT APPLICABLE.
JOINT RESEARCH AGREEMENT
NOT APPLICABLE.
FIELD OF THE INVENTION
The present invention provides peptides and analogs thereof and methods of using them for treating type 1 diabetes mellitus, type 2 diabetes mellitus and other conditions. The invention
Peptides, derivatives and analogs thereof, and methods of using same
Solo gli utenti registrati possono tradurre articoli
Entra registrati
C. REFERENCE TO GOVERNMENT GRANT
Not Applicable.
D. JOINT RESEARCH AGREEMENT
Not Applicable.
E. FIELD OF THE INVENTION
The present invention provides peptides and analogs thereof and methods of using them for treating type 1 diabetes mellitus, type 2 diabetes mellitus and other conditions. The
Il database di erbe medicinali più completo supportato dalla scienza
- Funziona in 55 lingue
- Cure a base di erbe sostenute dalla scienza
- Riconoscimento delle erbe per immagine
- Mappa GPS interattiva - tagga le erbe sul luogo (disponibile a breve)
- Leggi le pubblicazioni scientifiche relative alla tua ricerca
- Cerca le erbe medicinali in base ai loro effetti
- Organizza i tuoi interessi e tieniti aggiornato sulle notizie di ricerca, sperimentazioni cliniche e brevetti
Digita un sintomo o una malattia e leggi le erbe che potrebbero aiutare, digita un'erba e osserva le malattie ei sintomi contro cui è usata.
* Tutte le informazioni si basano su ricerche scientifiche pubblicate
